Atlas Trials

Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

Clinical trial NCT00239369 · COMPLETED

Trial details

NCT number
NCT00239369
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension
Start date
2005-10-01
Primary completion
2006-08-01
Enrollment
713

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.